ArticleCureus2026
Association of Serum Albumin Levels With Preeclampsia Severity and Fetomaternal Outcomes: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSerum albumin is frequently reduced in preeclampsia because of urinary protein loss, endothelial dysfunction, capillary leakage, and pregnancy-related haemodilution. Its value as an independent marker of severe disease or adverse pregnancy outcomes remains uncertain.
methodsThis hospital-based observational cross-sectional study included 150 women with singleton pregnancies and preeclampsia. The source report classified 99 women as having preeclampsia without severe features and 51 as having preeclampsia with severe features. Serum albumin was the primary biochemical parameter and was grouped as less than 2.5, 2.5 to less than 3.0, and 3.0 to 3.5 g/dL. Urine protein by dipstick, spot urine protein-to-creatinine ratio, and 24-hour urinary protein were also recorded as supportive renal measures. Maternal and perinatal outcomes were compared using chi-square or Fisher exact tests, with unadjusted risk ratios and 95% confidence intervals.
resultsThe mean serum albumin concentration was 3.08 ± 0.27 g/dL, and no participant had a value above 3.5 g/dL. Albumin below 3.0 g/dL was reported in 25 of 51 women (49.0%) with severe features and 24 of 99 (24.2%) without severe features (risk ratio 2.02, 95% confidence interval 1.29-3.16; p=0.003). Urine dipstick proteinuria of 3+ or 4+ was more frequent in women with severe features (27.5% versus 9.1%; risk ratio 3.02, 95% confidence interval 1.40-6.50; p=0.007). Severe features were also associated with preterm delivery before 37 weeks, neonatal intensive care admission, birth weight below 2 kg, and impending eclampsia. Caesarean delivery, a five-minute Apgar score below seven, and perinatal death did not differ significantly.
conclusionsThe absence of a higher-albumin comparator limited assessment of the prespecified 3.5 g/dL threshold. Albumin below 3.0 g/dL was associated with severe features in an exploratory unadjusted analysis, but an independent prognostic value was not established. Serum albumin should be interpreted as an adjunct to established clinical and laboratory severity criteria.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.